Hims & Hers planning to sell compounded peptides

Hims & Hers Health plans to sell compounded peptides, CEO Andrew Dudum announced on a Monday earnings call. The company is developing a peptides experience including U.S.-manufactured products, clinical-led guidance, and ongoing blood testing. The announcement came during the company's earnings call, with Dudum outlining the initiative as a best-in-class offering.